Paragon Wealth Strategies LLC Acquires 4 Shares of Johnson & Johnson (JNJ)

Paragon Wealth Strategies LLC raised its holdings in Johnson & Johnson (NYSE:JNJ) by 0.1% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,332 shares of the company’s stock after purchasing an additional 4 shares during the period. Johnson & Johnson accounts for about 0.9% of Paragon Wealth Strategies LLC’s holdings, making the stock its 15th biggest position. Paragon Wealth Strategies LLC’s holdings in Johnson & Johnson were worth $970,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of JNJ. Benedict Financial Advisors Inc. grew its stake in Johnson & Johnson by 1.3% during the first quarter. Benedict Financial Advisors Inc. now owns 53,888 shares of the company’s stock valued at $6,712,000 after acquiring an additional 672 shares in the last quarter. iAB Financial Bank grew its stake in Johnson & Johnson by 3.5% during the first quarter. iAB Financial Bank now owns 11,759 shares of the company’s stock valued at $1,465,000 after acquiring an additional 400 shares in the last quarter. Moloney Securities Asset Management LLC grew its stake in Johnson & Johnson by 16.7% during the first quarter. Moloney Securities Asset Management LLC now owns 48,412 shares of the company’s stock valued at $6,030,000 after acquiring an additional 6,925 shares in the last quarter. Clarkston Capital Partners LLC grew its stake in Johnson & Johnson by 5.4% during the first quarter. Clarkston Capital Partners LLC now owns 322,446 shares of the company’s stock valued at $40,161,000 after acquiring an additional 16,594 shares in the last quarter. Finally, Sumitomo Mitsui Asset Management Company LTD grew its stake in Johnson & Johnson by 4.1% during the first quarter. Sumitomo Mitsui Asset Management Company LTD now owns 281,410 shares of the company’s stock valued at $35,049,000 after acquiring an additional 11,194 shares in the last quarter. Hedge funds and other institutional investors own 65.61% of the company’s stock.

Several equities analysts recently commented on JNJ shares. Credit Suisse Group set a $154.00 price objective on shares of Johnson & Johnson and gave the company an “outperform” rating in a research note on Thursday, October 19th. Royal Bank Of Canada boosted their price objective on shares of Johnson & Johnson from $144.00 to $147.00 and gave the company an “outperform” rating in a research note on Wednesday, October 18th. Citigroup Inc. started coverage on shares of Johnson & Johnson in a research note on Monday, September 25th. They set a “neutral” rating and a $140.00 price objective for the company. Goldman Sachs Group, Inc. (The) cut shares of Johnson & Johnson from a “neutral” rating to a “sell” rating and boosted their price objective for the company from $125.00 to $130.00 in a research note on Wednesday, September 20th. Finally, Jefferies Group LLC raised shares of Johnson & Johnson from a “hold” rating to a “buy” rating and boosted their price objective for the company from $145.00 to $157.00 in a research note on Wednesday, October 11th. Four investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and eleven have issued a buy rating to the company’s stock. Johnson & Johnson currently has an average rating of “Hold” and an average price target of $143.70.

Shares of Johnson & Johnson (JNJ) opened at $138.34 on Wednesday. The firm has a market cap of $370,551.69, a P/E ratio of 19.32, a PEG ratio of 2.80 and a beta of 0.82. The company has a quick ratio of 1.02, a current ratio of 1.32 and a debt-to-equity ratio of 0.36. Johnson & Johnson has a 1-year low of $109.32 and a 1-year high of $144.35.

Johnson & Johnson (NYSE:JNJ) last announced its quarterly earnings data on Tuesday, October 17th. The company reported $1.90 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.80 by $0.10. Johnson & Johnson had a net margin of 21.28% and a return on equity of 27.38%. The firm had revenue of $19.65 billion during the quarter, compared to analyst estimates of $19.29 billion. During the same period in the previous year, the business posted $1.68 EPS. The business’s quarterly revenue was up 10.3% on a year-over-year basis. research analysts predict that Johnson & Johnson will post 7.28 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Tuesday, November 28th will be paid a $0.84 dividend. This represents a $3.36 annualized dividend and a dividend yield of 2.43%. The ex-dividend date is Monday, November 27th. Johnson & Johnson’s payout ratio is 58.33%.

WARNING: This story was first posted by Transcript Daily and is the sole property of of Transcript Daily. If you are viewing this story on another site, it was illegally copied and reposted in violation of U.S. and international copyright laws. The correct version of this story can be viewed at https://transcriptdaily.com/2017/11/22/paragon-wealth-strategies-llc-acquires-4-shares-of-johnson-johnson-jnj.html.

Johnson & Johnson Profile

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.

Institutional Ownership by Quarter for Johnson & Johnson (NYSE:JNJ)

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply